Skip to content
healthcare.dev
Get a free key

Docusate Sodium Oral Liquid

NDC 81033-022, Docusate Sodium Oral Liquid, liquid, from Kesin Pharma Corporation.

Product NDC
81033-022
Status
Listed
Labeler
Kesin Pharma Corporation
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M007
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81033-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOCUSATE SODIUM100 mg/10mL
Package NDCNDC-11Package
81033-022-5081033002250100 CUP, UNIT-DOSE in 1 CASE (81033-022-50) / 10 mL in 1 CUP, UNIT-DOSE (81033-022-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 81033-022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81033-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81033-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.